earnings
confidence high
sentiment positive
materiality 0.75
Aveanna Q4 2024 revenue $519.9M (+8.6%), net income $29.2M vs loss; Adj. EBITDA +42.8%; FY2025 guidance
Aveanna Healthcare Holdings, Inc.
- Q4 revenue $519.9M (+8.6% YoY); gross margin $171.7M (33.0%) up 15.7%.
- Q4 net income $29.2M vs net loss $25.7M; diluted EPS $0.14 vs ($0.13).
- Q4 adjusted net income $11.1M (+$14.3M); adjusted diluted EPS $0.05 vs ($0.02).
- Q4 Adjusted EBITDA $55.2M (+42.8%); FY2024 revenue >$2B, Adj. EBITDA >$183M.
- FY2025 guidance: revenue $2.10–$2.12B; Adj. EBITDA $190–$194M.